Pharmacy - Aegrotat Supplementary - Biochemistry Microbiology Immunology - PC 221 - Feb 2022

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

Student Number: Seat Number:

RHODES UNIVERSITY

FACULTY OF PHARMACY

SUPPLEMENTARY/AEGROTAT EXAMINATION: JANUARY/FEBRUARY 2022

BIOCHEMISTRY, MICROBIOLOGY, AND IMMUNOLOGY - PC 221

PAPER 2

Examiner: Dr N. Mutingwende MARKS: 100


DURATION: 3 HOURS
Moderator: Professor R. Tandlich PASS: 50

INSTRUCTIONS

1) The use of an English concise dictionary is NOT allowed.

2) ANSWER ALL QUESTIONS.

3) Please start each new full question on a separate page.

4) Please do NOT use red ink anywhere on your script.

5) Remember to FILL in the question numbers on the FRONT COVER of your answer
book.

6) ALL answers, including drawings, must be written in ink. Work written in pencil
WILL NOT be marked.

7) Write your student and seat number on Each page of the answer book.

8) PLEASE HAND IN THE QUESTION PAPER.

PLEASE DO NOT TURN OVER THIS PAGE UNTIL TOLD TO DO


SO.

Biochemistry, Microbiology, and Immunology – Paper 2 – Supp/Aeg – Jan/Feb 2022 Page 1 of 4


QUESTION 1
Describe the cycle of a lysogenic virus. Provide a short and theoretical justification for your
answer.
(8)

QUESTION 2

Environmental Health and Biotechnology Researchers (EHBR) at Rhodes University are


studying dormant ‘persister’ cells produced by Salmonella bacteria. Bacteria form these cells
when they are exposed to stresses such as antibiotics. By studying persister cells, EHB
researchers hope to understand the link between these dormant cells and antibiotic resistance,
as well as develop treatments that target persister cells directly. You are requested, in your
capacity as a PC221 student, to advise the EHBR group of researchers before they embark on
their research. Your discussion/advice leads should include but not limited to the following:
Mode of action of persister cells, difference between persisters and resistance, how persistent
infections lead to resistance, targeting persisters and persistent infection treatment. Begin
your introduction with the following phrase

Most antibiotics act only on….

(8)

QUESTION 3
Describe the structure of the SARS-CoV-2 virion and virocell. Provide a short and
theoretical justification for your answer.
(8)

QUESTION 4
What are the main structural differences between the virion and the ribovirocell? Provide a
short and theoretical justification for your answer.
(8)

Biochemistry, Microbiology, and Immunology - Paper 2- Supp/Aeg – Jan/Feb 2022 Page 2 of 4


QUESTION 5
What do you mean by epitope? Discuss the differences between affinity and avidity of an
antigen antibody reaction.
(8)

QUESTION 6
Human genes responsible for producing complex biological molecules such as hormones,
enzymes and cytokines can be inserted into bacterial cells. These cells are easily grown to
high cell densities in large volumes and the desired therapeutic materials produced on a large
scale. Using a human-derived gene of interest; bacterial DNA as a plasmid vector and
Escherichia coli as the host bacterium.
Outline and discuss, step by step, how you would make use of the host bacterium machinery
as a mechanism to produce the desired therapeutic materials from the gene of interest on a
large scale. Include all the necessary enzymes involved and materials.
(10)

QUESTION 7
Which is more primitive, innate immunity or adaptive immunity? Justify.
(8)

QUESTION 8

Briefly discuss the antigen processing by MHC class I or class II pathway.

(6)

QUESTION 9

Discuss how the body fights against a bacterial or viral infection. Think about all the probable
mechanisms possible.

(8)

Biochemistry, Microbiology, and Immunology - Paper 2- Supp/Aeg – Jan/Feb 2022 Page 3 of 4


QUESTION 10

A patient is undergoing the treatment of bacterial infections with an antibiotic drug. For a
while, he was responding to treatment. However, after six months, the patient relapsed: the
infection worsens even when the antibiotic's dosage increases. Based on what you have
learned in class:

(a) Suggest what has led to this possible mechanism that allowed the pathogens to become
resistant to the drug. (8)

(b) What would you propose as a new drug that would target these pathogens? Support
your reasons. (6)

QUESTION 11

Apart from using micro-organisms as synthetic factories for medicines, recombinant DNA
(rDNA) technology is used to produce pharmaceutically useful compounds of biological
origin not produced naturally by microorganisms.

(a) What is a recombinant protein? (3)


(b) Briefly discus the steps involved in the synthesis of a recombinant protein such as insulin
. (5)
(c) A growth cycle of a bacteria cell involves the production of both the primary and
secondary metabolites. What is the difference between primary and secondary
metabolites? Give an example for each.
(6)

TOTAL MARKS: 100

END OF EXAMINATION PAPER

Biochemistry, Microbiology, and Immunology - Paper 2- Supp/Aeg – Jan/Feb 2022 Page 4 of 4

You might also like